AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dousset, V.
Right arrow Articles by Petry, K.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dousset, V.
Right arrow Articles by Petry, K.G.

MR Imaging of Relapsing Multiple Sclerosis Patients Using Ultra-Small-Particle Iron Oxide and Compared with Gadolinium

V. Dousset, B. Brochet, M.S.A. Deloire, L. Lagoarde, B. Barroso, J.-M. Caille and K.G. Petry

From University Victor Segalen Bordeaux 2 and Centre Hospitalier Universitaire de Bordeaux, Laboratory of Neurobiology of Myelin Diseases, EA 2966, Bordeaux, France


Figure 1
View larger version (145K):

[in a new window]
 
Fig 1. Ultra-small-particle iron oxide (USPIO)- and gadolinium-enhanced multiple sclerosis (MS) lesions on several MR imaging sequences. MR imaging 1 performed with fluid-attenuated inversion recovery (FLAIR) (A), T2-weighted (B), T2*-weighted (C), and magnetization transfer T1-weighted postgadolinium images (D). Some MS lesions were enhanced by gadolinium. MR imaging 2, performed 24 hours after USPIO injection, shows an uptake of USPIO in 1 lesion on FLAIR (E), turbo spin echo (TSE) T2-weighted (F), T2*-weighted (G), and T1-weighted (H) images (short arrows). Veins are clearly seen as dark signal intensity on T2*-weighted images (G) (long arrow).


Figure 2
View larger version (165K):

[in a new window]
 
Fig 2. Mismatch of contrast agents uptake in an ultra-small-particle iron oxide (USPIO)-enhanced acute multiple sclerosis (MS) plaque. MR imaging 1 T2-weighted (A) and T1-weighted postgadolinium images (B) shows a large MS lesion that was not enhanced by gadolinium. MR imaging 2 shows the USPIO uptake at the periphery of the lesion (arrows), seen as a decreased signal intensity on T2-weighted images (C) and a high signal intensity on T1-weighted images (D). According to histologic observations (Lucchinetti et al, 2000), the number of macrophages at the center of acute MS lesions is usually minor.


Figure 3
View larger version (111K):

[in a new window]
 
Fig 3. Mismatch of contrast agent uptake in gadolinium-enhanced acute multiple sclerosis (MS) plaques. MR imaging 1 T1-weighted image (A) revealing the presence of 3 gadolinium-enhanced MS lesions (arrows). MR imaging 2 T1-weighted image (B) reveals USPIO enhancement in only one small lesion (arrow).